Please login to the form below

Not currently logged in
Email:
Password:

Takeda names Marc Princen as president of EUCAN

He previously served as a president at Merck

Takeda has appointed Marc Princen as corporate officer and president of the EUCAN (Europe and Canada) business unit.

In his new role, Princen will lead all business operations in Europe and Canada and will directly report to Christophe Weber, president and chief operating officer at Takeda.

Concerning the new appointment, Weber said: “I am fully confident that Marc, with his rich set of skills and expertise both broadly across the pharmaceutical industry and specifically in a majority of Takeda's therapeutic areas, will prove a great asset for Takeda.

“His passion for healthcare and commitment to improving lives are in alignment with Takeda's mission and core values of Takeda-ism and we are pleased to bring such a well-rounded leader on board.”

Princen brings more than 25 years of pharma industry experience to the role, including positions in commercial, marketing, business development and management around the world.

Most recently he served as president of the mid-Europe region at Merck & Co and prior to that, held the role of president and general manager of diversified brands.

Princen succeeds Trevor Smith, who will now work in the UK after commuting to Zurich for several years. Smith stepped down on November 1 and will aid the transition of leadership until his departure from Takeda on March 31, 2015.

26th November 2014

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...